Extensive exfoliative dermatitis induced by non-ionic contrast medium Iodixanol (Visipaque®) used during percutaneous coronary intervention

International Journal of Cardiology

Volumn 124, Issue 2, 2008, Pages

  Choi, Cheol Ung ^a   Rha, Seung Woon ^a   Suh, Soon Yong ^a   Kim, Jin Won ^a   Kim, Eung Ju ^a   Park, Chang Gyu ^a   Seo, Hong Seog ^a   Oh, Dong Joo ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Acute myocardial infarction; Exfoliative dermatitis; Non ionic contrast medium (Iodixanol)

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; IODIXANOL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG ELUTING STENT; EXFOLIATIVE DERMATITIS; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; THORAX RADIOGRAPHY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHEST PAIN; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DERMATITIS, EXFOLIATIVE; DRUG-ELUTING STENTS; EMERGENCY SERVICE, HOSPITAL; FOLLOW-UP STUDIES; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STEROIDS; TRIIODOBENZOIC ACIDS;

EID: 38649086694     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.179     Document Type: Article

References (6)

1. Sanchez-Perez J., F-Villalta M.G., Ruiz J.S., and Diez A.G. Delayed hypersensitivity reaction to the non-ionic X-ray contrast medium Visipaque (iodixanol). Contact Dermatitis (March 3 2003) 167-167 (1)
2. Hosoya T., Yamaguchi K., Akutsu T., et al. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 18 (2000) 39-45
3. Karakayli G., Beckham G., Orengo I., et al. Exfoliative dermatitis. Am Fam Physician 59 3 (February 1 1999) 625-635
4. Comert A., Akgun S., Civelek A., et al. Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia. Int J Dermatol 44 10 (2005) 882-884
5. Frishman W.H., Brosnan B.D., Grossman M., et al. Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev 10 6 (2002) 337-348
6. Mendez J., Sanchis M.E.., de la Fuente R., et al. Delayed-type hypersensitivity to subcutaneous enoxaparin. Allergy 53 10 (1998) 999-1003